By indication / Melanoma
Melanoma
5 imaging agents and 8 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [123I]iodoamphetamine | I-123 | — | 5 |
| [11C]AMT paired with [211At]At-211-AMT | C-11 | — | 3 |
| [18F]DK222 | F-18 | Research | 2 |
| [18F]MEL050 | F-18 | phase I | 1 |
| [18F]fluorophenylalanine | F-18 | first-in-human |
Therapy
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [212Pb]Pb-MC1L | Pb-212 | — | 4 |
| [131I]ICF01012 | I-131 | phase I clinical trial (first-in-human) | 3 |
| [225Ac]Ac-90-NM600 | Ac-225 | — | 2 |
| [67Cu]Cu-SARTATE paired with [64Cu]Cu-sartate | Cu-67 | preclinical study | 2 |
| [225Ac]Ac-DOTA-TA99 | Ac-225 | Reported once | 1 |
| [99mTc]Tc(CO)3-NOTA-PEG2Nle-CycMSHhex | Tc-99m | Reported once | 1 |
| [99mTc]Tc(CO)3-NOTA-AocNle-CycMSHhex | Tc-99m | Reported once | 1 |
| [131I]KN046 | I-131 | Reported once | 1 |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.
Get in touch